Bloodless medicine is an approach to medical and surgical care that avoids blood transfusions from donors. Instead of relying on banked blood products, doctors use a combination of strategies to boost your own blood supply before a procedure, minimize blood loss during it, and help your body recover afterward with the red blood cells it already has. What started largely as an accommodation for patients who refuse transfusions on religious grounds has grown into a mainstream medical philosophy now practiced at major hospital systems including Johns Hopkins, the Cleveland Clinic, and the University of Florida Health.
The World Health Organization released updated guidance in April 2025 encouraging health systems worldwide to adopt patient blood management programs, the clinical framework that bloodless medicine falls under. The shift reflects growing evidence that avoiding transfusions when possible can lead to comparable or even better outcomes for many patients.
The Three Phases of Bloodless Care
Bloodless medicine works across three stages: before, during, and after a procedure. Each phase uses different tools, but they share the same goal of keeping your red blood cell count high enough that a transfusion never becomes necessary.
Before surgery, the focus is on treating any existing anemia and building up your hemoglobin, the oxygen-carrying protein in red blood cells. Doctors typically aim for a hemoglobin level between 14 and 16 g/dL before a major operation. To get there, you may receive intravenous iron infusions and injections of a hormone that stimulates your bone marrow to produce more red blood cells. This preparation usually happens in outpatient visits over several weeks. Some patients need just two or three treatment sessions, while smaller patients facing high-blood-loss surgeries may need up to eight.
During surgery, the surgical team uses specialized techniques to limit how much blood leaves your body (more on those below). After the procedure, doctors continue monitoring your blood levels closely and use the same blood-building therapies to support your recovery, along with small-volume blood draws for lab tests so routine diagnostics don’t drain your reserves.
How Surgeons Minimize Blood Loss
Several techniques work together in the operating room to keep blood where it belongs.
Cell salvage is one of the most widely used. A specialized machine suctions blood from the surgical site as it’s lost, mixes it with an anticoagulant, and filters it. The collected blood then goes into a high-speed centrifuge that separates red blood cells from everything else based on density. Those red blood cells are washed in saline and returned to your bloodstream as a concentrated suspension. Because the blood never leaves a closed circuit and is your own, many patients who decline donor blood accept this technique.
Controlled hemodilution takes a different approach. Just before the operation begins, doctors draw a portion of your blood and replace the lost volume with a non-blood fluid to keep your blood pressure stable. You go into surgery with a normal blood volume but fewer red blood cells per unit of blood. The practical result: every drop lost during the procedure contains fewer red blood cells than it otherwise would. At the end of surgery, your stored blood is returned to you. The lower blood thickness during the operation also tends to reduce blood pressure slightly, which can further limit surgical bleeding.
Minimally invasive surgical techniques, including laparoscopic and robotic-assisted procedures, also play a role. Smaller incisions mean less tissue disruption and less bleeding overall.
Reducing Blood Loss Outside the Operating Room
Surgery isn’t the only place patients lose blood in a hospital. Routine lab draws are a surprisingly significant source of blood loss during a hospital stay. Standard blood collection tubes hold 2 to 10 milliliters each, and critically ill patients may have dozens of tubes drawn over the course of days or weeks. This can cause what’s called hospital-acquired anemia.
Bloodless medicine programs combat this by using smaller collection tubes and, where possible, capillary sampling from a finger stick instead of a full needle draw from a vein. Finger-stick collection requires less blood, causes less discomfort, and doesn’t require a trained phlebotomist. Coordinating lab orders so that multiple tests run from a single draw also helps preserve your blood volume during recovery.
How Outcomes Compare to Standard Care
One of the most common concerns about bloodless medicine is whether avoiding transfusions puts patients at greater risk. Research from Johns Hopkins, published by the International Anesthesia Research Society, compared outcomes between bloodless care patients and those who received standard transfusion-based treatment. Hospital stays were essentially identical: a median of 3 days for both groups across medical and surgical cases. In-hospital mortality was also similar.
Among medical (non-surgical) patients, those in the bloodless group actually had lower rates of hospital-acquired infections: 4.3% compared to 8.3% in the standard care group. After adjusting for differences between the patient populations, bloodless care was associated with a 44% lower risk of hospital-acquired infection in that subgroup. The difference wasn’t statistically significant for surgical patients, but importantly, surgical outcomes weren’t worse either.
These findings align with a broader shift in transfusion medicine. Major medical societies now recommend what’s called a restrictive transfusion strategy for stable patients. The Association for the Advancement of Blood and Biotherapies, drawing on data from over 20,000 adult participants across 45 clinical trials, strongly recommends not transfusing until hemoglobin drops to 7 g/dL. That’s a significant departure from the old standard of transfusing at 10 g/dL, and it reflects growing recognition that transfusions carry real risks, including immune reactions, infections, and inflammatory complications.
Who Bloodless Medicine Is For
Bloodless medicine was originally developed to serve Jehovah’s Witnesses, whose faith prohibits accepting blood transfusions. That community remains a core patient population. But the programs have expanded well beyond religious accommodation. Patients choose bloodless care for a variety of reasons: concerns about transfusion-transmitted infections, a history of transfusion reactions, personal preference, or simply because the evidence supports it for their specific procedure.
Not every patient is automatically a candidate for every bloodless procedure. For high-risk surgeries, doctors need to confirm that your hemoglobin can be safely optimized beforehand. In kidney transplant protocols, for example, bloodless programs typically require a pre-operative hemoglobin above 11 g/dL. The feasibility depends on your overall health, the expected blood loss of your procedure, and how much time is available to prepare.
If you’re pursuing bloodless care, you’ll typically complete an advance directive or similar legal document specifying that you decline blood products. This ensures your wishes are documented and respected even if you’re unable to communicate during an emergency. These forms function like any other advance directive for health care decisions and become part of your medical record.
Where Bloodless Programs Are Available
Dedicated bloodless medicine programs exist at dozens of major medical centers across the United States, and the number continues to grow. Johns Hopkins, Englewood Health in New Jersey, and UF Health in Florida operate some of the longest-running programs. Many other hospitals offer patient blood management services that incorporate the same techniques without branding them as “bloodless” programs specifically.
Globally, the WHO’s 2025 guidance is designed to help countries with limited resources establish patient blood management infrastructure. The guidance draws on the experience of health systems where these programs are well established and provides a framework for replication, with particular attention to reducing maternal deaths from postpartum hemorrhage and improving outcomes in trauma care. In practice, this means bloodless techniques are moving from specialty programs at elite hospitals toward becoming a standard part of how medicine is practiced worldwide.